Correlation Between NYSE Composite and DexCom

Can any of the company-specific risk be diversified away by investing in both NYSE Composite and DexCom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and DexCom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NYSE Composite and DexCom Inc, you can compare the effects of market volatilities on NYSE Composite and DexCom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of DexCom. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and DexCom.

Diversification Opportunities for NYSE Composite and DexCom

0.01

Correlation Coefficient

NYSE Composite  DexCom

Significant diversification

The 3 months correlation between NYSE and DexCom is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and DexCom Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DexCom Inc and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with DexCom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DexCom Inc has no effect on the direction of NYSE Composite i.e., NYSE Composite and DexCom go up and down completely randomly.

Pair Corralation between NYSE Composite and DexCom

Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.27 times more return on investment than DexCom. However, NYSE Composite is 3.69 times less risky than DexCom. It trades about 0.0 of its potential returns per unit of risk. DexCom Inc is currently generating about -0.1 per unit of risk. If you would invest  1,797,406  in NYSE Composite on March 12, 2024 and sell it today you would earn a total of  1,157  from holding NYSE Composite or generate 0.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NYSE Composite  vs.  DexCom Inc

Pair Trading with NYSE Composite and DexCom

The main advantage of trading using opposite NYSE Composite and DexCom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, DexCom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will offset losses from the drop in DexCom's long position.

The idea behind NYSE Composite and DexCom Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.